Trial Details

TERMINATED
Basic Information
Clinical ID c3029
Identifier NCT02620007
Trial Title Evaluation of Adherent Invasive E. Coli Eradication in Adult Crohn Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn Disease|Adherent-invasive E. Coli
Interventions DRUG: Ciprofloxacin|DRUG: Rifaximin|DRUG: Ciprofloxacin Placebo|DRUG: Rifaximin Placebo
Participant Information
Sponsor Assistance Publique - Hôpitaux de Paris
City Le Kremlin-Bicêtre
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2015-12
Primary Completion Date 2021-08
Completion Date 2022-06